ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0448

Aromatic Amino Acid-Derived Microbial Metabolites and Mortality Risk in ESKD

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Lin, Ting-yun, Taipei Tzu Chi Hospital, Taipei City, Taiwan
  • Hung, Szu-Chun, Taipei Tzu Chi Hospital, Taipei City, Taiwan
Background

Two novel gut microbiota-derived metabolites from aromatic amino acids, 4-OH-hippuric acid (from dietary tyrosine) and 5-OH-indole-3-acetic acid (from dietary tryptophan), have been identified as the strongest predictors of adverse outcomes in individuals with preserved kidney function. However, their prognostic significance in patients with end-stage kidney disease (ESKD) undergoing hemodialysis remains unclear.

Methods

We conducted a prospective cohort study of 329 hemodialysis patients (median age 67.5 years; 48.9% female; median dialysis vintage 5.5 years). Plasma concentrations of aromatic amino acids and their metabolites were quantified using stable isotope dilution liquid chromatography–tandem mass spectrometry. Cox proportional hazards models were used to estimate hazard ratios for all-cause mortality, adjusting for age, sex, diabetes, cardiovascular disease, dialysis vintage, C-reactive protein, and normalized protein catabolic rate.

Results

During a median follow-up of 5.0 years, 96 patients (35.7%) died. Higher plasma levels of 4-OH-hippuric acid (adjusted HR 1.65; 95% CI: 1.08–2.53; P = 0.022) and 5-OH-indole-3-acetic acid (adjusted HR 2.33; 95% CI: 1.13–4.80; P = 0.021) showed the strongest links to increased all-cause mortality. Compared to the lowest quartile, patients in the highest quartile of each metabolite conferred significantly higher mortality risks (HR 2.57 for 4-OH-hippuric acid and HR 2.73 for 5-OH-indole-3-acetic acid). In contrast, traditional uremic toxins such as p-cresol sulfate and indoxyl sulfate showed weaker or non-significant associations.

Conclusion

Elevated plasma concentrations of 4-OH-hippuric acid and 5-OH-indole-3-acetic acid are independently associated with higher all-cause mortality in hemodialysis patients. These findings extend previous observations from non-CKD populations and suggest that these gut-derived metabolites may serve as novel prognostic biomarkers or therapeutic targets in ESKD.

Funding

  • Private Foundation Support

Digital Object Identifier (DOI)